Sectors & IndustriesHealthcare

Best Healthcare Stocks to Buy Now (2025)

Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1124 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 48, which is 22 points higher than the healthcare sector average of 26. It passed 17 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 34.59% over the past year, overperforming other healthcare stocks by 89 percentage points.

Phibro Animal Health has an average 1 year price target of $21.50, a downside of -10.15% from Phibro Animal Health's current stock price of $23.93.

Phibro Animal Health stock has a consensus Sell recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 0% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 50% have issued a Strong Sell.

Enhabit (NYSE:EHAB) is the #2 top healthcare stock out of 1124 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Enhabit (NYSE:EHAB) is: Value: C, Growth: B, Momentum: C, Sentiment: B, Safety: A, Financials: B, and AI: C.

Enhabit (NYSE:EHAB) has a Due Diligence Score of 7, which is -19 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates EHAB as a "A".It passed 2 out of 33 due diligence checks and has weak fundamentals. Enhabit has seen its stock return 9.27% over the past year, overperforming other healthcare stocks by 64 percentage points.

Cumberland Pharmaceuticals (NASDAQ:CPIX) is the #3 top healthcare stock out of 1124 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Cumberland Pharmaceuticals (NASDAQ:CPIX) is: Value: B, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Cumberland Pharmaceuticals (NASDAQ:CPIX) has a Due Diligence Score of 26, which is equal to the healthcare sector average of 26. It passed 8 out of 33 due diligence checks and has average fundamentals. Cumberland Pharmaceuticals has seen its stock return 238.06% over the past year, overperforming other healthcare stocks by 293 percentage points.

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

Fresenius Medical Care Ag (NYSE:FMS) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 1.99%. Fresenius Medical Care Ag's dividend payout is not stable, having dropped more than 10% three times in the last 10 years. Fresenius Medical Care Ag's dividend has shown consistent growth over the last 10 years.

Fresenius Medical Care Ag's dividend payout ratio of 52.9% indicates that its dividend yield is sustainable for the long-term.

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 12.63%, which is 11 percentage points higher than the healthcare sector average of 1.99%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 32.4% indicates that its high dividend yield is sustainable for the long-term.

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.67%, which is 6 percentage points higher than the healthcare sector average of 1.99%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 160.3% indicates that its high dividend yield might not be sustainable for the long-term.

Healthcare stocks were down -1.23% in the last day, and down -1.3% over the last week. Biorestorative Therapies was the among the top losers in the healthcare sector, dropping -16% yesterday.

BioRestorative Therapies shares are trading lower. The company announced the presentation of promising preliminary blinded data from the first 36 subjects in its ongoing Phase 2 clinical trial of BRTX-100.

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 26 points higher than the healthcare sector average of 17. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 0.9% in the past year. It has overperformed other stocks in the healthcare sector by 56 percentage points.

Inmode (NASDAQ:INMD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Inmode's stock has dropped -26.59% in the past year. It has overperformed other stocks in the healthcare sector by 28 percentage points.

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 10.79% in the past year. It has overperformed other stocks in the healthcare sector by 66 percentage points.

50.72% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 48.16% over the next year.

4.35% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.25% of healthcare stocks are rated B (Buy), 44.98% are rated C (Hold), 25.88% are rated D (Sell), and 13.54% are rated F (Strong Sell).